Huw Jones

Huw Jones

Director Ejecutivo en THERACRYF PLC .

Fortuna: 587 $ al 30/04/2024

62 años
Health Technology
Commercial Services
Consumer Services

Origen de la red de primer grado Huw Jones.

EntidadTipo de entidadIndustria
6
Subsidiary Biotechnology 6
5
Private Company Biotechnology 5
Public Company Medical/Nursing Services 5
1
Subsidiary Miscellaneous Commercial Services 1

Gráfico Empresas conectadas de segundo grado

Relaciones con varias empresas

Empresas conectadas a Huw Jones a través de su red personal

EmpresaSectorPersonas relacionadasPuesto principal
Biotechnology

Laurent Audoly

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Laurent Audoly

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Laurent Audoly

Corporate Officer/Principal

Miscellaneous Commercial Services

Michael G. Moore

Susan Foden

Chief Executive Officer

Director/Board Member

Other Metals/Minerals

Karen O'Mahony

Director/Board Member

Vanderbilt University College/University

Laurent Audoly

Doctorate Degree

PROTEOME SCIENCES PLC Medical Specialties

Martin Diggle

Director/Board Member

OXFORD BIOMEDICA PLC Biotechnology

Martin Diggle

Director/Board Member

Investment Banks/Brokers

Karen O'Mahony

Corporate Officer/Principal

University of Oxford College/University

Susan Foden

Alan Barge

Martin Diggle

Christian Millar

Doctorate Degree

Graduate Degree

Graduate Degree

Graduate Degree

Pharmaceuticals: Major

Joe Dupere

Corporate Officer/Principal

Packaged Software

Nicholas Robbins-Cherry

Director of Finance/CFO

Investment Banks/Brokers

Karen O'Mahony

Director/Board Member

Investment Managers

Christian Millar

Corporate Officer/Principal

University of Vienna College/University

Toni Haenninen

Undergraduate Degree

University of South Florida College/University

Laurent Audoly

Undergraduate Degree

University College Dublin College/University

Karen O'Mahony

Graduate Degree

Trinity College Dublin College/University

Karen O'Mahony

Undergraduate Degree

University of St. Gallen College/University

Toni Haenninen

Undergraduate Degree

FARON PHARMACEUTICALS OY Pharmaceuticals: Major

Toni Haenninen

Director of Finance/CFO

Industrial Machinery

Toni Haenninen

Director of Finance/CFO

The University of Sheffield College/University

Glen Clack

Corporate Officer/Principal

The University of Nottingham College/University

Michael G. Moore

Doctorate Degree

University of Leicester College/University

Helen Kuhlman

Doctorate Degree

Building Products

Toni Haenninen

Director of Finance/CFO

Investment Managers

Helen Kuhlman

Private Equity Investor

SCANCELL HOLDINGS PLC Biotechnology

Martin Diggle

Director/Board Member

X-Rite Europe GmbH

Toni Haenninen

Director of Finance/CFO

BERGENBIO ASA Pharmaceuticals: Major

Susan Foden

Alan Barge

Chairman

Chief Tech/Sci/R&D Officer

TRI-STAR RESOURCES PLC Other Metals/Minerals

Karen O'Mahony

Chief Executive Officer

OXFORD BIODYNAMICS PLC Biotechnology

Christian Millar

Founder

Investment Managers

Martin Diggle

Founder

Financial Conglomerates

Karen O'Mahony

Chief Investment Officer

Aalto University School of Business College/University

Toni Haenninen

Masters Business Admin

BIODEXA PHARMACEUTICALS PLC Pharmaceuticals: Major

Nicholas Robbins-Cherry

Director of Finance/CFO

Internet Software/Services

Nicholas Robbins-Cherry

Director of Finance/CFO

Packaged Software

Gaby Salem

Director/Board Member

Packaged Software

Gaby Salem

Director/Board Member

KYMERA THERAPEUTICS, INC. Biotechnology

Laurent Audoly

Chief Executive Officer

Investment Managers

Karen O'Mahony

Chief Executive Officer

Other Metals/Minerals

Karen O'Mahony

Director/Board Member

Cytovia Holdings, Inc.

Laurent Audoly

Director/Board Member

Biotechnology

Laurent Audoly

Founder

Estadísticas

Internacional

Reino Unido 20
Estados Unidos 12
Irlanda 4
Suiza 3
Finlandia 3

Sectorial

Health Technology 14
Consumer Services 12
Finance 9
Technology Services 5
Non-Energy Minerals 4

Operativa

Director/Board Member 73
Chairman 18
Corporate Officer/Principal 17
Chief Executive Officer 12
Director of Finance/CFO 11
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA